{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Elevate&page=15", "query": { "intervention": "Elevate", "page": 15 }, "page_size": 10 }, "pagination": { "page": 15, "page_size": 10, "total_count": 17006, "total_pages": 1701, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Elevate&page=16&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Elevate&page=14&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T00:32:48.283Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07363616", "title": "Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity & Overweight", "Cardiometabolic Risk Factors" ], "interventions": [ { "name": "Mediterranean eating style", "type": "BEHAVIORAL" }, { "name": "Physical activity", "type": "BEHAVIORAL" }, { "name": "Mindful Eating", "type": "BEHAVIORAL" }, { "name": "Body Appreciation", "type": "BEHAVIORAL" }, { "name": "Enjoyable Exercise", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The Miriam Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2025-12-31", "completion_date": "2026-11-15", "has_results": false, "last_update_posted_date": "2026-01-23", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT07363616" }, { "nct_id": "NCT04335084", "title": "A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19", "Coronavirus Infection", "Sars-CoV2", "Corona Virus Infection", "COVID", "Coronavirus", "Coronavirus-19", "Coronavirus 19" ], "interventions": [ { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Vitamin C", "type": "DIETARY_SUPPLEMENT" }, { "name": "Vitamin D", "type": "DIETARY_SUPPLEMENT" }, { "name": "Zinc", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "ProgenaBiome", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 254, "start_date": "2020-06-22", "completion_date": "2024-04-11", "has_results": false, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 1, "location_summary": "Ventura, California", "locations": [ { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04335084" }, { "nct_id": "NCT03901547", "title": "Emotion Regulation and Burnout Impact on Communication Documentation", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Communication" ], "interventions": [ { "name": "Communication Skills Training", "type": "BEHAVIORAL" }, { "name": "Profile feedback", "type": "BEHAVIORAL" }, { "name": "Maslach burnout inventory", "type": "OTHER" }, { "name": "Emotion Regulation Skills Question (ERSQ)", "type": "OTHER" }, { "name": "Semi-structured interview", "type": "OTHER" }, { "name": "Priming", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2019-09-15", "completion_date": "2022-01-01", "has_results": false, "last_update_posted_date": "2023-08-01", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 1, "location_summary": "Lebanon, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT03901547" }, { "nct_id": "NCT05643638", "title": "A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graft Versus Host Disease, Acute" ], "interventions": [ { "name": "CYP-001: Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSCs)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Cynata Therapeutics Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2024-03-04", "completion_date": "2026-06-17", "has_results": false, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 13, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Jacksonville, Florida + 9 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Pembroke Pines", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05643638" }, { "nct_id": "NCT02311855", "title": "Duration of Immune Response to Influenza Vaccination in Patients With RA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Influenza vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Bassett Healthcare", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 87, "start_date": "2014-08", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2017-01-06", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 1, "location_summary": "Cooperstown, New York", "locations": [ { "city": "Cooperstown", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02311855" }, { "nct_id": "NCT05989126", "title": "Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Macular Edema (DME)", "Neovascular Age-Related Macular Degeneration (nAMD)" ], "interventions": [ { "name": "aflibercept 8 mg PFS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2024-04-15", "completion_date": "2024-05-31", "has_results": true, "last_update_posted_date": "2026-05-28", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 2, "location_summary": "Bellaire, Texas • The Woodlands, Texas", "locations": [ { "city": "Bellaire", "state": "Texas" }, { "city": "The Woodlands", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05989126" }, { "nct_id": "NCT02424578", "title": "Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Diclofenac Capsules low dose", "type": "DRUG" }, { "name": "Diclofenac Capsules high dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iroko Pharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "6 Years to 16 Years" }, "enrollment_count": 30, "start_date": "2015-05", "completion_date": "2016-04-19", "has_results": true, "last_update_posted_date": "2017-07-13", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 5, "location_summary": "Sheffield, Alabama • Little Rock, Arkansas • Durham, North Carolina + 2 more", "locations": [ { "city": "Sheffield", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02424578" }, { "nct_id": "NCT00988715", "title": "Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Myelomonocytic Leukemia", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Previously Treated Myelodysplastic Syndrome", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Refractory Anemia With Excess Blasts", "Refractory Cytopenia With Multilineage Dysplasia", "Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts", "Secondary Acute Myeloid Leukemia" ], "interventions": [ { "name": "Pretargeted Radioimmunotherapy", "type": "BIOLOGICAL" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Total-Body Irradiation", "type": "RADIATION" }, { "name": "Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Peripheral Blood Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Fludarabine Phosphate", "type": "DRUG" }, { "name": "Pharmacological Study", "type": "OTHER" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION", "PROCEDURE", "OTHER" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2010-04-21", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-08-30", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00988715" }, { "nct_id": "NCT06625515", "title": "First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumors", "Breast Cancer Recurrent", "Colorectal Cancer Metastatic", "Colon Cancer", "Rectal Adenocarcinoma", "Endometrial Cancer" ], "interventions": [ { "name": "ATX-559", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Accent Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2024-10-11", "completion_date": "2026-01-09", "has_results": false, "last_update_posted_date": "2026-02-24", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 5, "location_summary": "Aurora, Colorado • Oklahoma City, Oklahoma • Nashville, Tennessee + 2 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06625515" }, { "nct_id": "NCT03696615", "title": "Kettlebell Swings & Low Back Pressure Pain Threshold", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Low Back Pain" ], "interventions": [ { "name": "Tabata Kettlebell Swing Workout", "type": "OTHER" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Central Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 60, "start_date": "2014-08", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2018-10-04", "last_synced_at": "2026-10-27T00:32:48.283Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03696615" } ] }